Skin Cancer

A genetic counselor discussed the various hereditary breast and ovarian cancer syndrome-associated cancers among men and how to manage them at the FORCE Annual Meeting.

As part of the Bristol-Myers Squibb Coast 2 Coast 4 Cancer Research ride, 109 company employees rode from Oregon to New Jersey to help raise funds for the V Foundation for Cancer Research.

The panelists acknowledged that many individuals face barriers to receiving regular skin check-ups. Some people – especially those in rural areas – may not have a dermatologist near them. And even if they do make it in to a doctor’s office for a skin check-up, they may not be checked as thoroughly as they should be.

Lynn Schuchter, M.D., discussed immunotherapy and BRAF/MEK inhibition at the Melanoma Action Coalition’s Fall Conference.

Substitute thinking "life management" instead of "time management."

Two-time cancer survivor encourages fellow survivors to develop resilience to cope with cancer.

I felt like cancer had forced me to do other "uncomfortable" things instead of the bucket list I had chosen.

The Food and Drug Administration (FDA) granted priority review to a new supplemental biologics license application for Keytruda (pembrolizumab) to treat adult and pediatric patients with recurrent locally advanced or metastatic Merkel cell carcinoma, according to Merck, the agent’s manufacturer.

Researchers noted that melanoma diagnosis and treatment did not cause many women to put off becoming pregnant.

Individuals diagnosed with a high frequency of basal cell carcinomas, a common type of skin cancer, may be at an increased for developing an unrelated cancer, highlighting the need for additional clinical screening.

Research continues to drive the oncology field.

Patients who receive anti-PD-1 therapies may experience delayed cutaneous side effects like lesions, eczema or psoriasis, even after treatment has ended.

Clinical trials seek to discover new ways to attack the disease, limit metastasis and prevent recurrence.

Creating a medical family tree is helpful. If cancer is common, noting which branches include it can help inform decisions.

Understanding how melanoma spreads can lead to better outcomes. That's what researchers at UCSF aimed to do.

July is UV Safety Awareness Month. See three tips on how to protect yourself from harmful UV rays, which are the leading cause of skin cancer.

While having a career as a flight attendant allows individuals to travel the globe, exposure to carcinogens and frequent disruptions in circadian rhythms may increase cancer prevalence in these individuals, according to recent research published in the journal Environmental Health.

The FDA has approved the combination of the BRAF inhibitor Braftovi (encorafenib) and the MEK inhibitor Mektovi (binimetinib) for the treatment of patients with BRAF-mutant unresectable or metastatic melanoma, as detected by an FDA-approved test.

The FDA has accepted a supplemental biologics license application (sBLA) for the use of Keytruda (pembrolizumab) as an adjuvant treatment for patients with resected, high-risk stage 3 melanoma, according to Merck (MSD), the manufacturer of the PD-1 inhibitor.

In melanoma, combining two immunotherapies may lower costs and improve quality of life.

Novel immunotherapies either release the immune system’s parking brake or hit its gas pedal.

Oncolytic, or engineered, viruses that infect and kill cancer cells are showing promise.

Checkpoint inhibitors can be extremely effective for the right patients, but identifying who will benefit remains an imprecise science.

A new expert guideline for managing immunotherapy’s side effects has been released.

Study findings published in the Journal of the American Academy of Dermatology showed that once-daily aspirin use can increase the risk of melanoma in men — nearly double that of men who do not use aspirin each day.